Analystreport

Coherus Oncology (CHRS) had its "sell (d+)" rating reaffirmed by Weiss Ratings.

Coherus Oncology, Inc.  (CHRS) 
Last coherus oncology, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com